We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cutting-Edge AI Algorithms Enable Early Detection of Prostate Cancer

By LabMedica International staff writers
Posted on 05 Aug 2025

Prostate cancer is the second most common cancer among men worldwide and poses a major global health challenge due to the difficulty of detecting the disease in its early stages. More...

The lack of symptoms early on makes early screening and timely intervention particularly challenging. Although diagnostic methods such as prostate-specific antigen (PSA) tests and digital rectal exams are widely used, relying solely on PSA screening often leads to overdiagnosis and unnecessary biopsies. These limitations underscore the need for more precise and personalized diagnostic and treatment strategies. New artificial intelligence (AI) models are now helping to overcome these challenges by accurately identifying cancerous tissues, predicting patient outcomes, and streamlining treatment planning.

A team of researchers from Brown University Warren Alpert Medical School (Providence, RI, USA) and Shanghai Jiao Tong University School of Medicine (Shanghai, China) conducted a comprehensive review of AI-based models used in prostate cancer management. The review, published in the Chinese Medical Journal, highlights various AI tools developed to support diagnosis, treatment, prognosis prediction, and molecular subtyping of prostate cancer. For diagnosis, models like Asian Prostate Cancer Artificial Intelligence integrate multimodal clinical parameters to optimize screening and reduce unnecessary biopsies, while Galen Prostate employs convolutional neural networks (CNNs) to enhance Gleason grading post-biopsy. Imaging tools such as Fuzzy C-Means clustering algorithms and CNN-based MRI segmentation systems help detect and outline lesions in MRI scans. In therapy management, AI models like the Multimodal Artificial Intelligence Prostate Prognostic Model assist clinicians in determining which patients might benefit from short-term androgen deprivation therapy (ADT), thus guiding personalized treatment. Additional tools like random forest-based models and Virtual Treatment Planner automate and optimize radiotherapy planning, while Survival Quilt offers 10-year survival predictions. For monitoring recurrence and metastasis, models such as the Lymph Node Metastases Diagnostic Model and XGBoost provide accurate detection of micrometastases and biochemical recurrence.

These AI interventions have already demonstrated meaningful clinical benefits, offering faster, more reliable insights into cancer progression and treatment responses. By automating tasks traditionally dependent on human expertise, AI allows for greater precision and consistency in managing prostate cancer. However, the review also emphasizes the shift from traditional task-specific AI tools to foundational models capable of multitasking across broader datasets. This transition, while promising, presents new challenges, including the need for vast and diverse datasets and minimizing AI bias. Researchers have called for continued innovation and refinement of these tools, with a focus on making them more accessible and regulatory-compliant. As technology, regulation, and data infrastructure advance, AI is expected to play an even more transformative role in the future of precision medicine.

"In the future, as databases become more robust, algorithms are further refined, and supportive laws and regulations are developed, AI is poised to play an even more transformative role in precision medicine for PCa,” said Dr. Rui Chen, co-leader of the study.

Related Links:
Brown University Warren Alpert Medical School
Shanghai Jiao Tong University School of Medicine


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Genai-based pathological assessment workflow for lung adenocarcinoma (Shen J. et al., Int J Surg 111(7): 4252–4262; 2025)

Generative AI Demonstrates Expert-Level Pathological Assessment of Lung Cancer

Lung adenocarcinoma is one of the most difficult cancers to diagnose accurately, requiring pathologists to spend extensive time examining tissue samples under microscopes to determine tumor grades and... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.